Monitoring of mood stabilizing drugs for bipolar disorder in Australian general practice

Simple item page
dc.contributor.authorSchrader, G.
dc.contributor.authorDhillon, R.
dc.contributor.authorBastiampillai, T.
dc.contributor.authorAl Atrash-Najar, R.
dc.date.issued2002
dc.descriptionThe definitive version is available at www.blackwell-synergy.com
dc.description.abstractObjective: To determine adherence to guidelines by general practitioners for monitoring mood stabilizing drugs in patients with bipolar disorder. Method: A postal survey of general practitioners was conducted in a metropolitan division of general practitioners. Results: Substantial numbers of general practitioners appear to not be following established guidelines for the monitoring of mood stabilising drugs. Conclusion: Greater educational input is required to enable general practitioners to optimise care for patients with chronic psychiatric disorder.
dc.description.statementofresponsibilityGeoffrey Schrader, Rohan Dhillon, Tarun Bastiampillai, Rima Al Atrash-Najar
dc.identifier.citationAustralasian Psychiatry, 2002; 10(3):265-267
dc.identifier.doi10.1046/j.1440-1665.2002.00460.x
dc.identifier.issn1039-8562
dc.identifier.issn1440-1665
dc.identifier.orcidSchrader, G. [0000-0002-2504-8102]
dc.identifier.urihttp://hdl.handle.net/2440/38833
dc.language.isoen
dc.publisherInforma Healthcare-Taylor & Francis
dc.source.urihttps://doi.org/10.1046/j.1440-1665.2002.00460.x
dc.titleMonitoring of mood stabilizing drugs for bipolar disorder in Australian general practice
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Psychiatry publications